Wed, Aug-20-03, 14:10
|
|
Registered Member
Posts: 98
|
|
Plan: modified CDK
Stats: 182/174/168
BF:19%/17%/15%
Progress: 57%
Location: Northern Colorado
|
|
Osteoarthritis (OA), the most widespread type of arthritis, is a degenerative disease of the joints. Although sometimes capable of causing acute inflammation, it is most commonly a "wear-and-tear" disease involving degeneration of joint cartilage and formation of bony spurs within various joints. Trauma to the joints, repetitive occupational usage, and obesity are risk factors. Most people over 60 years of age have this affliction to some extent, with approximately 16 million sufferers requiring medical care. The main goal of treatment is to relieve pain
In recent years, glucosamine and chondroitin have been widely promoted as a treatment for OA. Glucosamine, an amino sugar, is thought to promote the formation and repair of cartilage. Chondroitin, a carbohydrate, is a cartilage component that is thought to promote water retention and elasticity and to inhibit the enzymes that break down cartilage. Both compounds are manufactured by the body.
Research Findings
Laboratory studies suggest that glucosamine may stimulate production of cartilage-building proteins. Other research suggests that chondroitin may inhibit production of cartilage-destroying enzymes and fight inflammation too. Glucosamine supplements are derived from shellfish shells; chondroitin supplements are generally made from cow cartilage. Human studies have shown that either one may relieve arthritis pain and stiffness with fewer side effects than conventional arthritis drugs. But two problems remain. First, there has not been enough high-quality or long-range research to determine whether their use is practical. Second, because dietary supplement manufacture is not regulated, product quality (especially of chondroitin products) is not assured.
|